Immunic Inc. (IMUX) Misses Q2 EPS by 1c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Co-Diagnostics (CODX) Tops Q2 EPS by $1.54, Beats on Revenue